UConn launched funding program for COVID-19 research
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
On Aug. 31, 2020, the Office of the Vice President for Research (OVPR) announced it had launched a…
On Aug. 31, 2020, T2 Biosystems announced that the FDA had issued an Emergency Use Authorization (EUA) for…
On Aug. 31, 2020, Novavax announced it had reached an agreement in principle with the Government of Canada…
On Aug. 31, 2020, BioCryst Pharmaceuticals announced that the National Institute of Allergy and Infectious Diseases (NIAID) had…
On Aug. 31, 2020, Todos Medical announced that it had entered into a sales agreement with a Wisconsin-based…
On Aug. 28, 2020, the FDA issued an emergency use authorization (EUA) to Yale School of Public Health…
On Aug. 28, 2020, the U.S. Dept. of Veterans Affairs (VA) announced a new clinical trial to study…
On Aug. 28, 2020, Gilead Sciences announced the FDA expanded the Emergency Use Authorization (EUA) enabling use of…
On Aug. 28, 2020, Moderna confirmed that the Company was engaged in discussions with the Ministry of Health,…
On Aug. 28, 2020, iBio announced that it had entered into an exclusive worldwide license agreement with Planet…
On Aug. 27, 2020, the National Cancer Institute (NCI) announced a partnership with Cancer Research UK to fund…
On Aug. 27, 2020, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes…
On Aug. 27, 2020, RedHill Biopharma announced that its U.S. Phase 2 study with opaganib (Yeliva®, ABC294640) in…
On Aug. 27, 2020, Vaccitech announced that it had received a non-dilutive Government grant to support research with…
On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense…
On Aug. 27, 2020, Laurent Pharmaceuticals announced that it had received approval from the U.S. Food and Drug…
On Aug. 27, 2020, scientists at Scripps Research announced they were partnering with peers in the U.S. and…
On Aug. 27, 2020, AIM ImmunoTech announced that it had identified an effective in vitro model at The…
On Aug. 27, 2020, Myriad RBM announced ultrasensitive immunoassays for viral pneumonia Including COVID-19 from our CLIA-certified laboratory….
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
On Aug. 27, 2020, Pfizer and Shanghai Fosun Pharmaceutical announced an intended collaboration to supply 10 million doses…
On Aug. 27, 2020, Assembly Biosciences and Arbutus Biopharma announced that the companies have entered into a clinical…
On Aug. 26, 2020, VBI Vaccines announced data from three preclinical mouse studies conducted to enable selection of…
On Aug. 26, 2020, the National Science Foundation (NSF) announced that it was establishing new artificial intelligence institutes…
On Aug. 26, 2020, Abbott announced the FDA had issued Emergency Use Authorization (EUA) for its BinaxNOWル COVID-19…
On Aug. 26, 2020, UConn announced that Thanh Duc Nguyen, Assistant Professor in the Departments of Mechanical Engineering…
On Aug. 26, 2020, researchers announced an inexpensive, sensitive, CRISPR-based tests diagnose two deadly viruses in settings with…
On Aug. 26, 2020, Altimmune announced additional positive results from the preclinical studies of its single-dose intranasal COVID-19…
On Aug. 26, 2020, Stereotaxis announced a pioneering publication in the prestigious Journal of the American College of…
On Aug. 26, 2020, Heat Biologics announced publication of positive preclinical COVID-19 results in bioRxiv. The company reported…